Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$0.283 – $0.322
Volume27,020
Market cap$1M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$982.83K
Price / earnings
—
Price / book
0.17×
Price / sales
—
EV / sales
—
EV / EBITDA
1.69×
Profitability
Earnings per share
-$0.84
Return on assets
-44.18%
Return on equity
-47.75%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
13.38×
Quick ratio
13.38×
Cash ratio
12.66×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$2.57M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for BBLG, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$0
$0
$0
$0
$0
$0
$0
$0
Selling, general and administrative
$423.77K
$499.36K
$663.46K
$475.91K
$527.47K
$556.47K
$614.91K
$450.37K
Research and development
$242.57K
$308.75K
$141.6K
$257.2K
$187.81K
$191.61K
$423.58K
$1.1M
Total operating expenses
$666.34K
$808.11K
$805.05K
$733.11K
$715.27K
$748.08K
$1.04M
$1.55M
Operating income
-$666.34K
-$808.11K
-$805.05K
-$733.11K
-$715.27K
-$748.08K
-$1.04M
-$1.55M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
-$617.65K
-$773.7K
-$765.99K
-$684.64K
-$666.74K
-$740.52K
-$1.02M
-$1.52M
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$617.65K
-$773.7K
-$765.99K
-$684.64K
-$666.74K
-$740.52K
-$1.02M
-$1.52M
Net income attributable to common shareholders
-$617.65K
-$773.7K
-$765.99K
-$684.64K
-$666.74K
-$740.52K
-$1.02M
-$1.52M
EBITDA
-$666.34K
-$808.11K
-$805.05K
-$733.11K
-$715.27K
-$748.08K
-$1.04M
-$1.55M
Basic earnings per share
-$0.17
-$0.43
-$0.43
-$0.38
-$0.37
-$1.33
-$1.92
-$3.67
Diluted earnings per share
-$0.17
-$0.43
-$0.43
-$0.38
-$0.37
-$1.33
-$1.92
-$3.67
Recent news
Company coverage with links to the original publishers.
Bone Biologics Corporation announced a private placement of 2.1 million shares at $1.42 per share, raising $3.0 million upfront with potential additional $6.0 million from warrant exercises. The company plans to use proceeds for clinical trials, patent portfolio maintenance, and working capital. Closing expected July 9, 2026.
Bone Biologics announced 2025 achievements including extending rhNELL-1 shelf life to 24 months, completing a $5 million public offering, filing new patent applications, and maintaining Nasdaq compliance. The company plans to continue advancing its NB1 clinical trial in 2026 with focus on patient enrollment completion and operational readiness.
Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering.
BioVie shares dipped 41.8% to $1.10 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
Ainos, Inc. (NASDAQ: AIMD) gained 112.3% to $2.23 in pre-market trading.
MSP Recovery, Inc. (NASDAQ: LIFW) shares rose 41.7% to $1.46 in pre-market trading. LifeWallet announced a comprehensive settlement with 28 affiliated property and casualty insurers, benefiting LifeWallet’s medicare clients across the U.S.
Jaguar Health, Inc. (NASDAQ: JAGX) shares rose 37.8% to $0.1220 in pre-market trading after surging 50% on Friday.
Renalytix Plc (NASDAQ: RNLX) gained 35.5% to $1.41 in pre-market trading. Renalytix recently announced that effective March 1, 2024, the United States Government has approved adding the company’s FDA de Novo Marketing authorized test, kidneyintelX.dkd, to its 10-year Governmentwide Acquisition Contract for early-stage kidney disease bioprognostic testing services.
Aadi Bioscience, Inc. (NASDAQ: AADI) shares surged 20.8% to $2.32 in pre-market ...
Shares of Etsy, Inc. (NASDAQ: ETSY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Etsy reported quarterly earnings of 62 cents per share which missed the analyst consensus estimate of 78 cents. The company reported quarterly sales of $842.3 million, beating the analyst consensus estimate of $827.81 million.
Etsy shares dipped 7.5% to $71.34 on Thursday.
Here are some other stocks moving in today's mid-day session.
Gainers
La Rosa Holdings Corp. (NASDAQ: LRHC) shares jumped 160.7% to $3.6499 after the company said it has acquired a 100% interest in the Company's franchisee - La Rosa Realty Winter Garden LLC located in Winter Garden, Florida.
BuzzFeed, Inc. (NASDAQ: BZFD) jumped 91.4% to $0.4150 after the company revealed the sale of Complex Networks to NTWRK, a live-streaming video commerce platform. The deal, valued at $108.6 million, will also result in a 16% reduction in BuzzFeed’s workforce.
Monopar Therapeutics Inc. (NASDAQ: MNPR) rose 80.7% to $1.03 after the company disclosed promising preclinical data for its MNPR-101 radiopharma program targeting advanced cancers.
Root, Inc. (NASDAQ: ROOT) shares gained 40.8% to $12.21 after posting better-than-expected fourth-quarter results.
Novavax, Inc. (NASDAQ: NVAX) jumped 34.7% to $5.36. Novavax has reached a settlement related to the 2021 advance purchase agreement for Novavax's prototype Covid-19 vaccine (NVX-COV2373).
EZFill Holdings Inc. (NASDAQ: EZFL) rose 34.3% to $1.86. EzFill announced preliminary 2023 revenues of $23 million, up 54% year over year.
Mercurity Fintech Holding Inc. (NASDAQ: MFH) jumped 30% to $2.93.
Mativ Holdings, Inc. (NYSE: MATV) gained 27.6% to $15.00 following upbeat earnings.
Venus Concept Inc. (NASDAQ: VERO) shares climbed 26.9% to $1.6242 after the company received CE Mark from DEKRA Certification B.V. to market Venus Versa Pro in Europe.
Outset Medical, Inc. (NASDAQ: OM) gained 26% to $4.0680 following upbeat results.
Ocular Therapeutix, Inc. (NASDAQ: OCUL) rose 22.2% to $9.19 after announcing a $325.0 million private ...
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.
The company grew deliveries by over 300% from Q3 to Q4, and total deliveries are approximately 4,700, with the majority being Fisker Ocean One launch edition vehicles priced at $68,999. In 2023, Fisker produced 10,142 Fisker Oceans and delivered approximately 4,700 vehicles.
Fisker shares jumped 20.8% to $1.8250 on Friday.
Here are some other stocks moving in today's mid-day session.
Gainers
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares climbed 132.6% to $4.8150.
Aditxt, Inc. (NASDAQ: ADTX) shares climbed 73.4% to $8.36. Aditxt recently entered into definitive agreement to acquire Evofem Biosciences, Inc.
China Green Agriculture, Inc. (NYSE: CGA) gained 68.3% to $3.1982. On Dec. 27, China Green Agriculture entered into a stock purchase agreement with Zhibiao Pan for the acquisition of all outstanding stock of Lonestar Dream for a total consideration of $49 million.
Sentage Holdings Inc. (NASDAQ: SNTG) gained 57% to $2.7802.
cbdMD, Inc. (NYSE: YCBD) shares climbed 55.7% to $1.2299 after gaining 11% on Thursday.
Jin Medical International Ltd. (NASDAQ: ZJYL) gained 40.8% to $245.00. The company recently received a letter from the Nasdaq indicating that a delisting action has been stayed.
SYLA Technologies Co., Ltd. (NASDAQ: SYT) rose 27.5% to $5.60. SYLA Technologies recently increased its FY23 guidance.
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose 17.8% to $0.3890. Titan Pharmaceuticals said its Board of Directors has approved a 1-for-20 reverse stock split.
Future FinTech Group Inc. (NASDAQ: FTFT) gained 14.7% to $2.33.
Kintara Therapeutics, Inc. (NASDAQ: KTRA) rose 14% to $0.22 after gaining 7% on Thursday.
Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.